Trial · NCT02906696
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Response Rate | Treatment (Bosutinib) | 6 | Participants | ||
| Number of Participants With Treatment Interruptions and Dose Reductions | Treatment (Bosutinib) | Interruptions | 6 | Participants | |
| Number of Participants With Treatment Interruptions and Dose Reductions | Treatment (Bosutinib) | Reductions | 4 | Participants | |
| Rates of Major Molecular Response (MR), MR4, MR4.5 and Complete Molecular Response | Treatment (Bosutinib) | Complete Molecular Response (CMR) | 2 | Participants | |
| Rates of Major Molecular Response (MR), MR4, MR4.5 and Complete Molecular Response | Treatment (Bosutinib) | MR4.5 | 3 | Participants | |
| Rates of Major Molecular Response (MR), MR4, MR4.5 and Complete Molecular Response | Treatment (Bosutinib) | MR4 | 3 | Participants | |
| Rates of Major Molecular Response (MR), MR4, MR4.5 and Complete Molecular Response | Treatment (Bosutinib) | Major Molecular Response (MMR) | 5 | Participants | |
| Rates of BCR-ABL/ABL <10% | Treatment (Bosutinib) | 3 | Participants | ||
| Rates of BCR-ABL/ABL < 1% | Treatment (Bosutinib) | 2 | Participants | ||
| Overall Survival | Treatment (Bosutinib) | 20.26 | Full Range 13.63 to 22.90 | Months | |
| Event-free Survival | Treatment (Bosutinib) | 13.97 | Full Range 3.06 to 22.90 | Months | |
| Transformation-free Survival | Treatment (Bosutinib) | 13.97 | Full Range 3.75 to 22.90 | Months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02906696/results